Investigative Urology - Results from #5020

Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy - Abstract January 4, 2013

Pathway crosstalk analysis based on protein-protein network analysis in prostate cancer - Abstract January 4, 2013

DNA vaccination for prostate cancer, from preclinical to clinical trials where-we stand? - Abstract January 4, 2013

Molecular phenotyping of circulating tumour cells in patients with prostate cancer: Prediction of distant metastases - Abstract January 4, 2013

4-O-methylhonokiol, a peroxisome proliferator activated receptor gamma agonist, inhibits prostate tumor growth: p21 Mediated suppression of NF-κB activity - Abstract January 4, 2013

Measuring oncogenic signaling pathways in cancer with PET: An emerging caradigm from studies in castration-resistant crostate cancer - Abstract January 4, 2013

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2 - Abstract January 4, 2013

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells - Abstract January 3, 2013

Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation - Abstract January 3, 2013

Modulation of signaling pathways in prostate cancer by green tea polyphenols - Abstract January 3, 2013

Regression of human prostate cancer xenografts in mice by MT112/BAY2010112, a novel PSMA/CD3-bispecific BiTE antibody crossreactive with non-human primate antigens - Abstract January 3, 2013

Evolution of end points for cancer immunotherapy trials - Abstract January 3, 2013

Combination immunotherapy approaches - Abstract January 3, 2013

15- lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells - Abstract January 3, 2013

Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate are a risk factor for prostate cancer in African Americans - Abstract January 3, 2013

Rad9 contributes to prostate tumor progression by promoting cell migration and anoikis resistance - Abstract January 3, 2013

Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer - Abstract January 3, 2013

HOXB13 is a susceptibility gene for prostate cancer: Results from the International Consortium for Prostate Cancer Genetics (ICPCG) - Abstract January 3, 2013

Multipotent and unipotent progenitors contribute to prostate postnatal development - Abstract January 2, 2013

FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide™) - Abstract January 2, 2013

Page 252 of 346